As many diagnostics companies continued to benefit from high volumes of COVID-19testing, cash burned a hole in the pockets of many in the industry, and major players and smaller newbies alike picked up new businesses.
Published in 360Dx
Author: Kelsy Ketchum
Abstract:
As many diagnostics companies continued to benefit from high volumes of COVID-19testing, cash burned a hole in the pockets of many in the industry, and major players and smaller newbies alike picked up new businesses.
PR Newswire / June 16, 2025 SALT LAKE CITY, June 16, 2025 /PRNewswire/ — Averra Holdings, LLC (“Averra”), a portfolio company of Banner Capital, is pleased to announce a partnership with ZIEN Medical Technologies (“ZIEN”). Read More
Read MoreOutcome Capital Life Science Market Pulse May 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?